首页 | 本学科首页   官方微博 | 高级检索  
     


Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma
Authors:Focosi Daniele  Cecconi Nadia  Boni Giuseppe  Orciuolo Enrico  Galimberti Sara  Petrini Mario
Affiliation:Division of Hematology, Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, Italy. focosi@icgeb.org
Abstract:We report here a patient with relapsed follicular lymphoma who developed secondary acute myeloid leukaemia 15 months after radioimmunotherapy (RIT) with (90)Y-ibritumomab tiuxetan, the fifth described case to date. We review the literature for the potential causal relationship between RIT and secondary myelodysplastic syndromes/acute myeloid leukaemia.
Keywords:acute myeloid leukaemia  ibritumomab  radioimmunotherapy
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号